Cargando…

All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture

SUMMARY: In the first year, after an osteoporotic fracture of a hip, forearm, upper arm, or spine, the dispensing rates of antidepressants and benzodiazepines increased significantly. After those fractures, recent and past use of antidepressants and benzodiazepines was associated with increased all-...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bruin, I. J. A., Klop, C., Wyers, C. E., Overbeek, J. A., Geusens, P. P. M. M., van den Bergh, J. P. W., Driessen, J. H. M., de Vries, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422967/
https://www.ncbi.nlm.nih.gov/pubmed/30737577
http://dx.doi.org/10.1007/s00198-019-04851-9
_version_ 1783404451341533184
author de Bruin, I. J. A.
Klop, C.
Wyers, C. E.
Overbeek, J. A.
Geusens, P. P. M. M.
van den Bergh, J. P. W.
Driessen, J. H. M.
de Vries, F.
author_facet de Bruin, I. J. A.
Klop, C.
Wyers, C. E.
Overbeek, J. A.
Geusens, P. P. M. M.
van den Bergh, J. P. W.
Driessen, J. H. M.
de Vries, F.
author_sort de Bruin, I. J. A.
collection PubMed
description SUMMARY: In the first year, after an osteoporotic fracture of a hip, forearm, upper arm, or spine, the dispensing rates of antidepressants and benzodiazepines increased significantly. After those fractures, recent and past use of antidepressants and benzodiazepines was associated with increased all-cause mortality; current use was not associated with mortality risk. INTRODUCTION: It remains unclear to what extent use of antidepressants and benzodiazepines is associated with mortality risk after a major osteoporotic fracture (MOF). We aimed to study the cumulative use of antidepressants and benzodiazepines during the year after MOF or hip fracture (HF) and whether the use was associated with mortality. METHODS: A cohort study was performed within the Dutch PHARMO Database Network including all patients aged 65+ with a first record of MOF (hip, humerus, forearm, and clinical vertebral fracture) between 2002 and 2011. Data were analyzed using Cox regression models, adjusted for comorbidities, and concomitant medication use and broken down to index fracture type. RESULTS: A total of 4854 patients sustained a first MOF, of whom 1766 patients sustained a HF. Mean follow-up was 4.6 years, divided in 30-day periods. The cumulative antidepressant and benzodiazepine use during the first year after MOF increased from 10.6 to 14.7% and from 24.0 to 31.4%, respectively. Recent (31–92 days before each follow-up period) and past use (> 92 days before) of antidepressants and benzodiazepines after MOF or HF was associated with an increased all-cause mortality risk but current use (< 30 days before) was not. CONCLUSION: There is a considerable increase in dispensing rate of antidepressants and benzodiazepines in the first year after a MOF. Recent and past use of these medications was associated with all-cause mortality. The finding that current use was not associated with mortality should be further explored and may probably be explained by the healthy survivor’s bias.
format Online
Article
Text
id pubmed-6422967
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-64229672019-04-05 All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture de Bruin, I. J. A. Klop, C. Wyers, C. E. Overbeek, J. A. Geusens, P. P. M. M. van den Bergh, J. P. W. Driessen, J. H. M. de Vries, F. Osteoporos Int Original Article SUMMARY: In the first year, after an osteoporotic fracture of a hip, forearm, upper arm, or spine, the dispensing rates of antidepressants and benzodiazepines increased significantly. After those fractures, recent and past use of antidepressants and benzodiazepines was associated with increased all-cause mortality; current use was not associated with mortality risk. INTRODUCTION: It remains unclear to what extent use of antidepressants and benzodiazepines is associated with mortality risk after a major osteoporotic fracture (MOF). We aimed to study the cumulative use of antidepressants and benzodiazepines during the year after MOF or hip fracture (HF) and whether the use was associated with mortality. METHODS: A cohort study was performed within the Dutch PHARMO Database Network including all patients aged 65+ with a first record of MOF (hip, humerus, forearm, and clinical vertebral fracture) between 2002 and 2011. Data were analyzed using Cox regression models, adjusted for comorbidities, and concomitant medication use and broken down to index fracture type. RESULTS: A total of 4854 patients sustained a first MOF, of whom 1766 patients sustained a HF. Mean follow-up was 4.6 years, divided in 30-day periods. The cumulative antidepressant and benzodiazepine use during the first year after MOF increased from 10.6 to 14.7% and from 24.0 to 31.4%, respectively. Recent (31–92 days before each follow-up period) and past use (> 92 days before) of antidepressants and benzodiazepines after MOF or HF was associated with an increased all-cause mortality risk but current use (< 30 days before) was not. CONCLUSION: There is a considerable increase in dispensing rate of antidepressants and benzodiazepines in the first year after a MOF. Recent and past use of these medications was associated with all-cause mortality. The finding that current use was not associated with mortality should be further explored and may probably be explained by the healthy survivor’s bias. Springer London 2019-02-08 2019 /pmc/articles/PMC6422967/ /pubmed/30737577 http://dx.doi.org/10.1007/s00198-019-04851-9 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
de Bruin, I. J. A.
Klop, C.
Wyers, C. E.
Overbeek, J. A.
Geusens, P. P. M. M.
van den Bergh, J. P. W.
Driessen, J. H. M.
de Vries, F.
All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
title All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
title_full All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
title_fullStr All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
title_full_unstemmed All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
title_short All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
title_sort all-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422967/
https://www.ncbi.nlm.nih.gov/pubmed/30737577
http://dx.doi.org/10.1007/s00198-019-04851-9
work_keys_str_mv AT debruinija allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture
AT klopc allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture
AT wyersce allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture
AT overbeekja allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture
AT geusensppmm allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture
AT vandenberghjpw allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture
AT driessenjhm allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture
AT devriesf allcausemortalitywithcurrentandpastuseofantidepressantsorbenzodiazepinesaftermajorosteoporoticandhipfracture